Related Experiment Videos
Severe rheumatoid valvular heart disease.
1Unidad de Biología Celular e Inmunogenética, Corporación para Investigaciones Biológicas, Universidad del Rosario, Cra. 72-A No 78-B-141, Medellín, Colombia. janaya@cib.org.co
Clinical Rheumatology
|October 27, 2005
Summary
Rheumatoid arthritis (RA) can affect the heart, sometimes causing endocarditis. Etanercept effectively managed both joint and heart complications in two RA patients.
Area of Science:
- Rheumatology
- Cardiology
- Immunology
Background:
- Rheumatoid arthritis (RA) is a systemic inflammatory condition.
- Extra-articular manifestations, including cardiac involvement, are recognized in RA.
- Cardiac compromise in RA is often subclinical.
Observation:
- Two cases of rheumatoid arthritis-associated endocarditis are presented.
- One patient required surgical valve replacement due to severe endocarditis.
- Both patients experienced articular and extra-articular RA manifestations.
Findings:
- Etanercept demonstrated efficacy in managing both the articular and cardiac aspects of RA in these cases.
- The study highlights the potential for RA to cause endocarditis.
- Successful treatment of RA-related endocarditis with etanercept was observed.
Implications:
- This suggests etanercept may be a valuable therapeutic option for managing cardiac complications in RA.
- Early recognition and management of cardiac involvement in RA are crucial.
- Further research into the cardiovascular impact of RA and its treatment is warranted.